isoproterenol and atosiban

isoproterenol has been researched along with atosiban in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruckmaier, RM; Inderwies, T; Kiossis, E; Riedl, J1
Advenier, C; Bardou, M; Breuiller-Fouché, M; Cecchi, R; Croci, T; Descamps, L; Fradin, Y; Germain, G; Guagnini, F; Leroy, MJ; Marini, P; Pascal, M; Rouget, C; Viviani, N1
Devost, D; Goupil, E; Hébert, TE; Iorio-Morin, C; Laporte, SA; Pétrin, D; Wrzal, PK; Zingg, HH1

Other Studies

3 other study(ies) available for isoproterenol and atosiban

ArticleYear
Effects of alpha- and beta-adrenergic receptor stimulation and oxytocin receptor blockade on milking characteristics in dairy cows before and after removal of the teat sphincter.
    The Journal of dairy research, 2003, Volume: 70, Issue:3

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Cattle; Female; Hormone Antagonists; Isoproterenol; Kinetics; Lactation; Mammary Glands, Animal; Milk; Milk Ejection; Phenylephrine; Pressure; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Oxytocin; Vasotocin

2003
In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agoni
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 321, Issue:3

    Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Benzoates; Binding, Competitive; Cell Line; Cell Line, Tumor; Cells, Cultured; Cyclic AMP; Female; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoproterenol; Macaca fascicularis; Molecular Structure; Myometrium; Obstetric Labor, Premature; Oxytocin; Pregnancy; Propanolamines; Receptors, Adrenergic, beta-3; Sulfonamides; Tocolytic Agents; Transfection; Uterine Contraction; Vasotocin

2007
Allosteric interactions between the oxytocin receptor and the β2-adrenergic receptor in the modulation of ERK1/2 activation are mediated by heterodimerization.
    Cellular signalling, 2012, Volume: 24, Issue:1

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Allosteric Regulation; Atenolol; Cell Line; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Female; Humans; Immunoprecipitation; Isoproterenol; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myometrium; Oxytocin; Phosphorylation; Propranolol; Protein Binding; Protein Multimerization; Receptors, Adrenergic, beta-2; Receptors, Oxytocin; Recombinant Fusion Proteins; Signal Transduction; Timolol; Vasotocin

2012